Gb 37 - analogs
| Prices in pharmacies: Instructions Gb 37 | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Strychninum purum ✘ (incl) Standacillin ✘ (incl) Tacrolimus-Akri ✘ (incl) Wobenzym ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 30% Liv 4 neutral
- 27% Gb 34 neutral
- 27% Liv 14 neutral
- 25% Gb 40 neutral
- 23% Kid 6 neutral
- 23% Liv 5 neutral
- 23% Ren 5 neutral
- 22% Bl 18 neutral
- 21% Kid 10 neutral
- 21% Liv 8 neutral
- 21% Du 4 neutral
- 20% Sp 9 neutral
- 20% Liv 3 neutral
- 20% Sp 2 neutral
- 20% Ren 3 neutral
- 20% St 37 neutral
- 20% Du 1 neutral
- 19% Liv 1 neutral
- 19% St 41 neutral
- 18% Lu 5 neutral
- 18% Sp 8 neutral
- 18% P 5 neutral
- 17% Kid 4 neutral
- 17% Sp 5 neutral
- 17% Liv 2 neutral
- 17% Ren 4 neutral
- 17% Gb 39 neutral
- 17% Liv 13 neutral
- 17% Si 7 neutral
- 17% Ren 6 neutral
- 17% Du 14 neutral
- 17% Bl 58 neutral
- 17% Bl 25 neutral
- 17% Si 2 neutral
- 17% Gb 41 neutral
- 17% P 6 neutral
- 16% Tb 6 neutral
- 16% Sp 1 neutral
- 16% St 40 neutral
- 16% Gb 12 neutral
- 16% L.i. 3 neutral
- 16% Tb 4 neutral
- 16% Ren 14 neutral
- 16% St 39 neutral
- 15% L.i. 2 neutral
- 15% Bl 40 neutral
- 15% Sp 6 neutral
- 15% Kid 3 neutral
- 15% Si 1 neutral
- 15% Ren 1 neutral
Learn more about the selection of analogues
▶
- The drug has «Gb 37» 51 analog by action, the most similar - Liv 4 .
- Medical online service has selected the best substitutes for Gb 37 based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Gb 37 to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.